Prognostic Significance of Vascular Endothelial Growth Factor Protein Levels in Oral and Oropharyngeal Squamous Cell Carcinoma
Adult
Male
Lymphokines
Chi-Square Distribution
Neovascularization, Pathologic
Endothelial Growth Factors
Middle Aged
Prognosis
Disease-Free Survival
3. Good health
Cohort Studies
Immunoenzyme Techniques
Oropharyngeal Neoplasms
03 medical and health sciences
0302 clinical medicine
Predictive Value of Tests
Carcinoma, Squamous Cell
Humans
Female
Mouth Neoplasms
Neoplasm Recurrence, Local
Aged
Proportional Hazards Models
DOI:
10.1200/jco.2000.18.10.2046
Publication Date:
2017-02-24T09:23:15Z
AUTHORS (5)
ABSTRACT
PURPOSE: Vascular Endothelial Growth Factor (VEGF) promotes angiogenesis in many different tumor types. VEGF levels may affect growth, metastatic potential, and response to radiotherapy. This study assesses the prognostic value of protein a cohort patients with oral oropharyngeal squamous cell carcinomas. The relationships between clinical outcome covariables tumor-node-metastasis stage, disease stage (I IV), grade, margin status, race, sex, age were also determined. PATIENTS AND METHODS: Chart review identified 77 or carcinoma treated gross total surgical resection postoperative radiation 1981 1992. Sufficient follow-up data tissue available 56 (73%). determined using immunohistochemistry. association covariables, was assessed bivariate multivariate model two-sided statistical tests. RESULTS: Twenty-three tumors (41%) positive for expression. VEGF-positive more likely recur locally (relative risk [RR] = 3.08; 95% confidence interval [CI], 1.03 9.24) distantly (RR 4.62; CI, 1.41 15.10). In analysis, positivity most significant predictor poor disease-free survival 2.66; 1.27 5.56) overall 3.21; 1.63 6.32). 2.75; 1.30 5.79) 3.53; 1.75 7.13). CONCLUSION: this cohort, prognosis. status prove be an important factor head neck cancer.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (195)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....